215 related articles for article (PubMed ID: 30070081)
1. Low-density lipoprotein-decorated and Adriamycin-loaded silica nanoparticles for tumor-targeted chemotherapy of colorectal cancer.
Shi G; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Zhang R
Adv Clin Exp Med; 2019 Apr; 28(4):479-487. PubMed ID: 30070081
[TBL] [Abstract][Full Text] [Related]
2. Low density lipoprotein modified silica nanoparticles loaded with docetaxel and thalidomide for effective chemotherapy of liver cancer.
Ao M; Xiao X; Ao Y
Braz J Med Biol Res; 2018 Jan; 51(3):1-10. PubMed ID: 29513882
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein decorated silica nanoparticles co-delivering sorafenib and doxorubicin for effective treatment of hepatocellular carcinoma.
Ye J; Zhang R; Chai W; Du X
Drug Deliv; 2018 Nov; 25(1):2007-2014. PubMed ID: 30799656
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein decorated and indocyanine green loaded silica nanoparticles for tumor-targeted photothermal therapy of breast cancer.
Pan H; Sun Y; Cao D; Wang L
Pharm Dev Technol; 2020 Mar; 25(3):308-315. PubMed ID: 31820663
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin Loaded Silica Nanoparticles with Dual Modification as a Tumor-Targeted Drug Delivery System for Colon Cancer Therapy.
Lin YQ; Zhang J; Liu SJ; Ye H
J Nanosci Nanotechnol; 2018 Apr; 18(4):2330-2336. PubMed ID: 29442900
[TBL] [Abstract][Full Text] [Related]
6. Chondroitin sulfate modified and adriamycin preloaded hybrid nanoparticles for tumor-targeted chemotherapy of lung cancer.
Liang X; Liang X
Kaohsiung J Med Sci; 2021 May; 37(5):411-418. PubMed ID: 33340254
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy.
Zhu QL; Zhou Y; Guan M; Zhou XF; Yang SD; Liu Y; Chen WL; Zhang CG; Yuan ZQ; Liu C; Zhu AJ; Zhang XN
Biomaterials; 2014 Jul; 35(22):5965-76. PubMed ID: 24768047
[TBL] [Abstract][Full Text] [Related]
8. Cetuximab conjugated and doxorubicin loaded silica nanoparticles for tumor-targeting and tumor microenvironment responsive binary drug delivery of liver cancer therapy.
Wang JK; Zhou YY; Guo SJ; Wang YY; Nie CJ; Wang HL; Wang JL; Zhao Y; Li XY; Chen XJ
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():944-950. PubMed ID: 28482611
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
Lee CS; Kim H; Yu J; Yu SH; Ban S; Oh S; Jeong D; Im J; Baek MJ; Kim TH
Eur J Med Chem; 2017 Dec; 142():416-423. PubMed ID: 28870452
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of adriamycin-encapsulated nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran.
Choi KC; Bang JY; Kim C; Kim PI; Lee SR; Chung WT; Park WD; Park JS; Lee YS; Song CE; Lee HY
J Pharm Sci; 2009 Jun; 98(6):2104-12. PubMed ID: 18823029
[TBL] [Abstract][Full Text] [Related]
11. Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles.
Kim JH; Kim Y; Bae KH; Park TG; Lee JH; Park K
Mol Pharm; 2015 Apr; 12(4):1230-41. PubMed ID: 25686010
[TBL] [Abstract][Full Text] [Related]
12. Chlorins e6 loaded silica nanoparticles coated with gastric cancer cell membrane for tumor specific photodynamic therapy of gastric cancer.
Yang J; Teng Y; Fu Y; Zhang C
Int J Nanomedicine; 2019; 14():5061-5071. PubMed ID: 31371947
[No Abstract] [Full Text] [Related]
13. Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells.
Liu Y; Chen Q; Xu M; Guan G; Hu W; Liang Y; Zhao X; Qiao M; Chen D; Liu H
Int J Nanomedicine; 2015; 10():1855-67. PubMed ID: 25834425
[TBL] [Abstract][Full Text] [Related]
14. Cancer cell membrane coated silica nanoparticles loaded with ICG for tumour specific photothermal therapy of osteosarcoma.
Zhang J; Miao Y; Ni W; Xiao H; Zhang J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2298-2305. PubMed ID: 31174440
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES).
Siddiqui A; Gupta V; Liu YY; Nazzal S
Int J Pharm; 2012 Jul; 431(1-2):222-9. PubMed ID: 22562053
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy.
Kang KW; Chun MK; Kim O; Subedi RK; Ahn SG; Yoon JH; Choi HK
Nanomedicine; 2010 Apr; 6(2):210-3. PubMed ID: 20060074
[TBL] [Abstract][Full Text] [Related]
17. Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer.
Meng LX; Ren Q; Meng Q; Zheng YX; He ML; Sun SY; Ding ZJ; Li BC; Wang HY
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S556-S563. PubMed ID: 30146920
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanoparticles co-loaded with doxorubicin and α-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models.
Oliveira MS; Aryasomayajula B; Pattni B; Mussi SV; Ferreira LAM; Torchilin VP
Int J Pharm; 2016 Oct; 512(1):292-300. PubMed ID: 27568499
[TBL] [Abstract][Full Text] [Related]
19. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
20. Janus "nano-bullets" for magnetic targeting liver cancer chemotherapy.
Shao D; Li J; Zheng X; Pan Y; Wang Z; Zhang M; Chen QX; Dong WF; Chen L
Biomaterials; 2016 Sep; 100():118-33. PubMed ID: 27258482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
